- Corporate Officers - H
- Henderson Molly
Insider Trading History of Henderson Molly
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henderson Molly since 2008.
This trader's CIK number is 1363812.
At the time of last reporting, Henderson Molly was the CFO and CBO of Phathom Pharmaceuticals, Inc.. (stock ticker symbol PHAT).
Also see all insider trading activities at Phathom Pharmaceuticals, Inc..
Note that in the past
Henderson Molly also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Phathom Pharmaceuticals, Inc. (PHAT) by Henderson Molly
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | PHAT | 0 | $0 | 3,678 | $16,738 | 0 | $0 |
2024 | PHAT | 0 | $0 | 15,358 | $148,043 | 0 | $0 |
2023 | PHAT | 0 | $0 | 24,160 | $211,889 | 0 | $0 |
2022 | PHAT | 6,000 | $0 | 4,318 | $41,452 | 0 | $0 |
Yearly summary of insider trading at Virtualscopics, Inc. (VSCP) by Henderson Molly
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | VSCP | 8,000 | $7,200 | 0 | $0 | 0 | $0 |
2008 | VSCP | 6,440 | $4,379 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Urogen Pharma Ltd. (URGN) by Henderson Molly
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | URGN | 0 | $0 | 331 | $2,508 | 666 | $0 |
2021 | URGN | 2,500 | $39,625 | 2,587 | $31,121 | 5,000 | $0 |
Insider trading activities at 3 companies by Henderson Molly:
1. Phathom Pharmaceuticals, Inc. (PHAT)
2. Virtualscopics, Inc. (VSCP)
3. Urogen Pharma Ltd. (URGN)
Table 1. Insider trading of Phathom Pharmaceuticals, Inc. (PHAT) by Henderson Molly
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-04-07 | PHAT | Sale | 3,678 | 4.55 | 16,738 |
2024-12-19 | PHAT | Sale | 1,291 | 8.00 | 10,328 |
2024-07-15 | PHAT | Sale | 4,325 | 11.72 | 50,689 |
2024-04-08 | PHAT | Sale | 3,435 | 11.10 | 38,128 |
2024-01-19 | PHAT | Sale | 6,307 | 7.75 | 48,898 |
2023-11-20 | PHAT | Sale | 2,127 | 7.24 | 15,403 |
2023-11-01 | PHAT | Sale | 12,492 | 8.38 | 104,620 |
2023-06-02 | PHAT | Sale | 1,960 | 11.41 | 22,367 |
2023-05-22 | PHAT | Sale | 2,110 | 12.87 | 27,164 |
2023-04-06 | PHAT | Sale | 3,439 | 7.27 | 25,001 |
2023-03-01 | PHAT | Sale | 2,032 | 8.53 | 17,334 |
2022-11-21 | PHAT | Sale | 2,159 | 9.60 | 20,726 |
2022-11-21 | PHAT | Sale | 2,159 | 9.60 | 20,726 |
2022-05-13 | PHAT | Buy | 6,000 | .00 | 0 |
Table 2. Insider trading of Virtualscopics, Inc. (VSCP) by Henderson Molly
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-06-19 | VSCP | Buy | 8,000 | .90 | 7,200 |
2008-03-14 | VSCP | Buy | 6,440 | .68 | 4,379 |
Table 3. Insider trading of Urogen Pharma Ltd. (URGN) by Henderson Molly
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-01-31 | URGN | Option Ex | 666 | .00 | 0 |
2022-01-31 | URGN | Sale | 331 | 7.58 | 2,508 |
2021-11-30 | URGN | Sale | 2,587 | 12.03 | 31,121 |
2021-11-30 | URGN | Option Ex | 5,000 | .00 | 0 |
2021-05-17 | URGN | Buy | 2,500 | 15.85 | 39,625 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henderson Molly
(CFO and CBO of Phathom Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.